Palmer Square Capital BDC Inc. PSBD 深 滬
已收盤 02-06 16:00:00 美东时间
11.45
-0.070
-0.61%
華盛通- 最 高11.60
- 今 開11.47
- 成交量 5.69万股
- 最 低 11.41
- 昨 收 11.52
- 總市值 3.60亿
- 52周最高 14.24
- 市盈率 靜 7.83
- 換手率 0.18%
- 52周最低 10.2423
- 委 比 0.00%
- 總股本 3147.89万
- 歷史最高 14.50
- 量 比 0.84
- 振 幅 1.65%
- 歷史最低 10.2423
- 每 手 1
- 風險率 0.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Palmer Square Capital BDC Inc. to Release Earnings and Host Conference Call
Palmer Square Capital BDC Inc. to Release Earnings and Host Conference Call Palmer Square Capital BDC Inc. will release its financial results for the fourth quarter and full year ended December 31, 2025, before the market opens on Thursday, February 26, 2026. Results will be available on the Palmer
01-28 05:05
Palmer Square Capital BDC Declares Q4 Supplemental Dividend Of $0.07/Share
Palmer Square Capital BDC Inc. (NYSE: PSBD) ("Palmer Square" or the "Company"), an externally managed business development company, today announced that its Board of Directors has declared a fourth quarter 2025
2025-12-23 21:36
This Ambev Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-11-26 20:38
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
2025-11-20 10:28
UBS Maintains Neutral on Palmer Square Capital BDC, Lowers Price Target to $13
UBS analyst Vilas Abraham maintains Palmer Square Capital BDC (NYSE:PSBD) with a Neutral and lowers the price target from $13.5 to $13.
2025-11-19 23:15
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
2025-10-15 18:20
Palmer Square Capital BDC Inc. Updates Q3 NAV
Palmer Square Capital BDC Inc. ( ($PSBD) ) has shared an announcement. Palmer S...
2025-10-15 04:56
UBS Maintains Neutral on Palmer Square Capital BDC, Lowers Price Target to $13.5
UBS analyst Vilas Abraham maintains Palmer Square Capital BDC (NYSE:PSBD) with a Neutral and lowers the price target from $14.5 to $13.5.
2025-10-15 00:44
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
2025-10-02 15:08
JP Morgan Downgrades Palmer Square Capital BDC to Neutral, Lowers Price Target to $12
JP Morgan analyst Melissa Wedel downgrades Palmer Square Capital BDC (NYSE:PSBD) from Overweight to Neutral and lowers the price target from $14 to $12.
2025-10-01 19:06
